A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers

Wound Repair and Regeneration

Volumn 20, Issue 4, 2012, Pages 500-511

  Meaume, Sylvie ^a   Truchetet, François ^b   Cambazard, Frédéric ^c   Lok, Catherine ^d   Debure, Clélia ^e   Dalac, Sophie ^f   Lazareth, Isabelle ^g   Sigal, Michèle Léa ^h   Sauvadet, Anne ⁱ   Bohbot, Serge ⁱ   Dompmartin, Anne ^j  

^a HÔPITAL ROTHSCHILD   (France)

^b Beauregard Hospital   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e Paris Descartes University   (France)

^f HÔPITAL DU BOCAGE   (France)

^g SAINT JOSEPH HOSPITAL   (France)

^h CENTRE HOSPITALIER VICTOR DUPOUY   (France)

ⁱ Laboratoires URGO ^*  (France)

^j CHU Clemenceau   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NANO OLIGOSACCHARIDE FACTOR; UNCLASSIFIED DRUG; URGOSTART; WOUND HEALING PROMOTING AGENT;

ADULT; AGED; APPLICATION SITE ECZEMA; APPLICATION SITE INFECTION; APPLICATION SITE INFLAMMATION; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; ARTICLE; COLLOID; COMPRESSION THERAPY; CONTACT DERMATITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEG ULCER; LIPIDO COLLOID TECHNOLOGY NANO OLIGOSACCHARIDE FACTOR WOUND DRESSING; LIPIDO COLLOID TECHNOLOGY WOUND DRESSING; MAJOR CLINICAL STUDY; MALE; NANOTECHNOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN MACERATION; ULCER; UNSPECIFIED SIDE EFFECT; WOUND DRESSING; WOUND HEALING;

AGED; BANDAGES, HYDROCOLLOID; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; INTENTION TO TREAT ANALYSIS; LEG; MALE; OLIGOSACCHARIDES; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; TIME FACTORS; VARICOSE ULCER; WOUND HEALING;

EID: 84863469018     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00797.x     Document Type: Article

References (45)

1. Valencia IC, Falabella A, Kirsner RS, Eaglstein WH,. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44: 401-421.
2. Graham ID, Harrison MB, Nelson EA, Lorimer K, Fisher A,. Prevalence of lower-limb ulceration: a systematic review of prevalence studies. Adv Skin Wound Care 2003; 16: 305-316.
3. Abbade LP, Lastoria S,. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 2005; 44: 449-456. (Pubitemid 40867547)
4. Khan MN, Davies CG,. Advances in the management of leg ulcers: the potential role of growth factors. Int Wound J 2006; 3: 113-120. (Pubitemid 44400782)
5. Herber OR, Schnepp W, Rieger MA,. A systematic review on the impact of leg ulceration on patients' quality of life. Health Qual Life Outcomes 2007; 5: 44.
6. Hareendran A, Doll H, Wild DJ, Moffatt CJ, Musgrove E, Wheatley C, Franks PJ,. The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Rep Reg 2007; 15: 465-473. (Pubitemid 47087638)
7. O'Meara S, Cullum NA, Nelson EA,. Compression for venous leg ulcers. Cochrane Database Syst Rev 2009; (1): CD000265.
8. Jones KR,. Why do chronic venous leg ulcers not heal? J Nurs Care Qual 2009; 24: 116-124; quiz 125-6.
9. Palfreyman S, Nelson EA, Michaels JA,. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007; 335: 244.
10. Chaby G, Senet P, Vaneau M, Martel P, Guillaume JC, Meaume S, Téot L, Debure C, Dompmartin A, Bachelet H, Carsin H, Matz V, Richard JL, Rochet JM, Sales-Aussias N, Zagnoli A, Denis C, Guillot B, Chosidow O,. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol 2007; 143: 1297-1304. (Pubitemid 47607683)
11. Rayment EA, Upton Z, Shooter GK,. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 2008; 158: 951-961. (Pubitemid 351521431)
12. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS,. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 2002; 10: 26-37. (Pubitemid 34496479)
13. Liu Y, Min D, Bolton T, Nubé V, Twigg SM, Yue DK, McLennan SV,. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 2009; 32: 117-119. Epub 2008 Oct 3.
14. Coulomb B, Couty L, Fournier B, Laurensou C, Aillaud C, Lafont A, Gogly B,. A NOSF (Nano-Oligasaccharide Factor) lipido-colloid dressing inhibits MMP in an in vitro dermal equivalent model. Wound Rep Reg 2008; 16: A66-82 (Meeting of the European Tissue Repair Society).
15. Couty L, Fournier B, Laurensou C, Bouschbacher M, Aillaud C, Gogly B, Coulomb B,. A NOSF (Nano-Oligasaccharide Factor) lipido-colloid dressing stimulates MMPs/TIMPs complexes formation leading to MMPs inhibition in an in vitro dermal equivalent model. Wound Rep Reg 2009; 16: A54-87 (Meeting of the European Tissue Repair Society and Wound Healing Society).
16. Schmutz JL, Meaume S, Fays S, Ourabah Z, Guillot B, Thirion V, Collier M, Barrett S, Smith J, Bohbot S, Dompmartin A,. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial. Int Wound J 2008; 5: 172-182. (Pubitemid 351731669)
17. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L,. Mechanism of action of Promogran®, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Rep Reg 2002; 10: 16-25. (Pubitemid 34496478)
18. Cullen B, Watt PW, Lundqvist C, Silcock D, Schmidt RJ, Bogan D, Light ND,. The role of oxidized regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 2002; 34: 1544-1556.
19. Bonett DG, Price RM,. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods 2002; 7: 370-383.
20. Meaume S, Ourabah Z, Cartier H, Granel-Brocard F, Combemale P, Bressieux JM, Bohbot S,. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers. J Wound Care 2005; 14: 329-334.
21. Ma KK, Chan MF, Pang SMC,. The effectiveness of using a lipidocolloid dressing for patients with traumatic digital wounds. Clin Nurs Res 2006; 15: 119-134. (Pubitemid 43494293)
22. Viennet C, Bride J, Gabiot AC, Humbert P,. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices. J Wound Care 2003; 12: 385-390.
23. Bernard FX, Barrault C, Juchaux F, Laurensou C, Apert L,. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing. J Wound Care 2005; 14: 215-220.
24. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H,. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016. Epub 2002 May 25. (Pubitemid 34762196)
25. Toy LW,. Matrix metalloproteinases: their function in tissue repair. J Wound Care 2005; 14: 20-22.
26. Hjerppe A, Saarinen JP, Venermo MA, Huhtala HS, Vaalasti A,. Prolonged healing of venous leg ulcers: the role of venous reflux, ulcer characteristics and mobility. J Wound Care 2010; 19: 474; 476, 478 passim.
27. Coulomb B, Couty L, Fournier B, Laurensou C, Aillaud C, Gogly B, Lafont A,. Evaluation de la matrice imprégnée de NOSF (nano-oligosaccharide factor), dans un modèle de reconstruction dermique in vitro. J Plaies Cicatris 2008; 14: 54-57.
28. Chaby G, Viseux V, Ramelet AA, Ganry O, Billet A, Lok C,. Refractory venous leg ulcers: a study of risk factors. Dermatol Surg 2006; 32: 512-519.
29. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA,. The accuracy of venous leg ulcer prognostic models in a wound care system. Wound Rep Reg 2004; 12: 163-168. (Pubitemid 38520682)
30. Reich-Schupke S, Murmann F, Altmeyer P, Stücker M,. Quality of life and patients' view of compression therapy. Int Angiol 2009; 28: 385-393.
31. Dereure O, Vin F, Lazareth I, Bohbot S,. Compression and peri-ulcer skin in outpatients' venous leg ulcers: results of a French survey. J Wound Care 2005; 14: 265-275.
32. Gilman T,. Wound outcomes: the utility of surface measures. Int J Low Extrem Wounds 2004; 3: 125-132.
33. Gelfand JM, Hoffstad O, Margolis DJ,. Surrogate endpoints for the treatment of venous leg ulcers. J Invest Dermatol 2002; 119: 1420-1425. (Pubitemid 36005630)
34. Cardinal M, Eisenbud DE, Phillips T, Harding K,. Early healing rates and wound area measurements are reliable predictors of later complete wound closure. Wound Rep Reg 2008; 16: 19-22.
35. Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA,. Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2003; 26: 1696-1700. (Pubitemid 36929106)
36. Steed DL, Hill DP, Woodske ME, Payne WG, Robson MC,. Wound-healing trajectories as outcome measures of venous stasis ulcer treatment. Int Wound J 2006; 3: 40-47.
37. Letouze A, Voinchet V, Hoecht B, Muenter KC, Vives F, Bohbot S,. Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies. J Wound Care 2004; 13: 221-225.
38. Blanchet-Bardon C, Bohbot S,. Using Urgotul dressing for the management of epidermolysis bullosa skin lesions. J Wound Care 2005; 14: 490-491, 494-6.
39. Burton F,. An evaluation of non-adherent wound-contact layers for acute traumatic and surgical wounds. J Wound Care 2004; 13: 371-373.
40. Furtado K, Pina E, Moffatt CJ, Franks PJ,. Leg ulceration in Portugal: quality of life. Int Wound J 2008; 5: 34-39. (Pubitemid 351379722)
41. Palfreyman S,. Assessing the impact of venous ulceration on quality of life. Nurs Times 2008; 104: 34-37.
42. Jull A, Parag V, Walker N, Rodgers A,. Responsiveness of generic and disease-specific health-related quality of life instruments to venous ulcer healing. Wound Rep Reg 2010; 18: 26-30.
43. González-Consuegra RV, Verdú J,. Quality of life in people with venous leg ulcers: an integrative review. J Adv Nurs 2011; 67: 926-944.
44. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G,. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 1999; 7: 442-452. (Pubitemid 30027566)
45. Veves A, Sheehan P, Pham HT,. A randomized controlled trial of Promogran® (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137: 822-827. (Pubitemid 34743174)